Online citations, reference lists, and bibliographies.
Referencing for people who value simplicity, privacy, and speed.
Get Citationsy
← Back to Search

Identification Of The High Risk Angioplasty Patient

S. Ellis
Published 1991 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
A recognition and understanding of the factors that make a patient truly at high risk for unsupported coronary angioplasty (PTCA) are necessary for the proper implementation of supported PTCA or an avoidance of the technique of PTCA altogether.
This paper references
10.7326/0003-4819-81-4-500
Drugs five years later: dextran 40.
J. L. Data (1974)
10.1016/S0735-1097(85)80099-1
The plights of the invasive treatment of ischemic heart disease
J. Kirklin (1985)
10.1016/0735-1097(88)90431-7
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
T. Ryan (1988)
10.1016/0002-9149(86)90860-X
Transluminal catheter reperfusion: a new technique to reestablish blood flow after coronary occlusion during percutaneous transluminal coronary angioplasty.
T. Hinohara (1986)
10.1016/0002-9149(89)90091-X
Early results and long-term outcome of percutaneous transluminal coronary angioplasty in patients age 75 years or older.
M. Imburgia (1989)
10.1016/0033-0620(81)90021-9
The intermediate coronary syndrome.
P. Scanlon (1981)
10.1016/0735-1097(89)90575-5
Fluid dynamics model of mitral valve flow: description with in vitro validation.
J. D. Thomas (1989)
10.1016/0002-9149(87)90796-X
Usefulness of percutaneous transluminal coronary angioplasty for unstable angina pectoris after non-Q-wave acute myocardial infarction.
R. Safian (1987)
10.1016/S0735-1097(98)90054-7
Transluminal intracoronary reperfusion catheter: a device to maintain coronary perfusion between failed coronary angioplasty and emergency coronary bypass surgery.
T. Hinohara (1988)
10.1016/S0735-1097(87)80075-X
Percutaneous transluminal angioplasty of stenotic coronary artery bypass grafts: 5 years' experience.
G. Côté (1987)
10.1016/0735-1097(88)92601-0
Application of percutaneous transluminal coronary angioplasty to the internal mammary artery graft.
T. Shimshak (1988)
10.5555/URI:PII:0022214367900248
The effect of clinical dextran on platelet aggregation, adhesion, and ADP release in man: in vivo and in vitro studies.
H. Weiss (1967)
10.1161/01.CIR.77.3.526
The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attacks.
K. Gotoh (1988)
10.1161/01.CIR.78.2.486
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
T. Ryan (1988)
10.1056/NEJM198508083130602
Emergency coronary angioplasty in refractory unstable angina.
P. D. de Feyter (1985)
10.1161/01.CIR.68.4.725
Acute occlusion after percutaneous transluminal coronary angioplasty--a new approach.
J. Hollman (1983)
10.1016/S0735-1097(87)80458-8
Multicenter study of percutaneous transluminal angioplasty for right coronary artery ostial stenosis.
E. Topol (1987)
10.1002/CCD.1810170106
Early occlusion following successful coronary angioplasty: clinical and angiographic observations.
T. Goldbaum (1989)
10.1016/0002-9149(89)91070-9
Safety and efficacy of percutaneous transluminal coronary angioplasty performed at time of diagnostic catheterization compared with that performed at other times.
J. O'Keefe (1989)
10.1161/01.CIR.80.1.1
Endothelium‐Derived Relaxing Factor and Coronary Vasospasm
P. VanHoutte (1989)
10.1161/01.CIR.78.3.712
Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug.
J. Y. Lam (1988)
10.1016/S0002-9149(73)80001-3
Unstable angina pectoris: morbidity and mortality in 57 consecutive patients evaluated angiographically.
C. Conti (1973)
10.1002/CCD.1810130204
Initial and late results of coronary angioplasty for early postinfarction unstable angina.
S. Gottlieb (1987)
10.1172/JCI109661
Effect of heparin and heparin fractions on platelet aggregation.
E. Salzman (1980)
10.1056/NEJM198810273191701
Aspirin, heparin, or both to treat acute unstable angina.
P. Théroux (1988)
10.1056/NEJM198806303182603
Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty.
L. Schwartz (1988)
10.1161/01.CIR.74.6.1365
Coronary angioplasty for early postinfarction unstable angina.
P. D. de Feyter (1986)
10.1016/S0735-1097(88)80017-2
Balloon angioplasty of aortocoronary saphenous vein bypass grafts: a histopathologic study of six grafts from five patients, with emphasis on restenosis and embolic complications.
R. Saber (1988)
10.1056/NEJM197306072882301
The intermediate coronary syndrome: clinical, angiographic and therapeutic aspects.
S. J. Fischl (1973)
10.1016/S0022-5223(19)37694-9
Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality from the Collaborative Study in Coronary Artery Surgery (CASS).
J. W. Kennedy (1980)
10.1002/CCD.1810130602
Comparative safety and efficacy of percutaneous transluminal coronary angioplasty in men and in women.
P. McEniery (1987)
10.1161/01.CIR.72.6.1177
Clinical pharmacology of platelet cyclooxygenase inhibition.
C. Patrono (1985)
10.1161/01.CIR.32.6.1020
Anatomy of the Coronary Arteries in Health and Disease
T. James (1965)
10.1136/hrt.32.6.728
Quantitative study of infarcted myocardium in cardiogenic shock.
C. Harnarayan (1970)
10.1126/SCIENCE.377493
Heparin neutralization of PGI2: effects upon platelets.
H. Saba (1979)
10.1161/01.CIR.78.6.1323
Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty. A quantitative arteriographic analysis.
T. Fischell (1988)
10.1016/0002-8703(89)90612-1
Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty.
S. Ellis (1989)
Effect of cimetidine on bioavailability of enteric-coated aspirin tablets.
Paton Tw (1983)
10.1002/CCD.1810150102
Percutaneous angioplasty of coronary bypass grafts: an emerging consensus.
W. Kussmaul (1988)
10.1055/S-0038-1649447
Effect of dextran infusion on the adenosine diphosphate induced adhesiveness and the spreading capacity of human blood platelets.
S. Bygdeman (1966)
10.1016/0002-8703(82)90268-X
Intracoronary thrombolysis in syndromes of unstable ischemia: angiographic and clinical results.
G. Vetrovec (1982)
10.1016/S0735-1097(83)80315-5
Percutaneous transluminal coronary angioplasty in patients with prior coronary bypass surgery.
J. Douglas (1983)
10.1161/01.CIR.78.5.1121
Emergency stenting for acute occlusion after coronary balloon angioplasty.
U. Sigwart (1988)
10.1161/01.CIR.77.2.372
Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty.
S. Ellis (1988)
10.1161/01.CIR.78.3.654
Importance of adequate heparin dosage in arterial angioplasty in a porcine model.
M. Heras (1988)
10.1016/0002-9149(84)90738-0
Acute coronary events associated with percutaneous transluminal coronary angioplasty.
M. Cowley (1984)
10.1016/S0002-8703(76)80119-6
Unstable angina pectoris.
J. Cairns (1976)
10.1016/S0002-8703(77)80278-0
Quantitative study on the size of coronary artery supplying areas postmortem.
H. Kalbfleisch (1977)
10.1016/0735-1097(88)90082-4
In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8,207 procedures.
S. Ellis (1988)
10.1016/0735-1097(88)92593-4
Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry.
D. Holmes (1988)
10.1016/0735-1097(88)90086-1
Comparison of predictions based on observational data with the results of randomized controlled clinical trials of coronary artery bypass surgery.
M. Hlatky (1988)
10.1016/0002-9149(88)90901-0
Early and long-term results of percutaneous transluminal coronary angioplasty in patients 70 years of age and older with angina pectoris.
C. Simpfendorfer (1988)
10.1016/0735-1097(88)92623-X
Intracoronary verapamil for reversal of refractory coronary vasospasm during percutaneous transluminal coronary angioplasty.
D. Babbitt (1988)
10.1056/NEJM198610093151501
Coronary angioscopy in patients with unstable angina pectoris.
C. Sherman (1986)
10.1016/0002-9149(84)90217-0
Efficacy of adjunctive dextran during percutaneous transluminal coronary angioplasty.
K. Swanson (1984)
10.1016/0002-9149(88)90304-9
Percutaneous transluminal coronary angioplasty in octogenarians.
M. Kern (1988)
10.1161/01.CIR.75.6.1192
A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.
H. Gold (1987)
10.1016/0002-8703(89)90851-X
Short-, medium-, and long-term follow-up after percutaneous transluminal coronary angioplasty for stable and unstable angina pectoris.
O. Kamp (1989)
10.1016/0002-8703(88)90803-4
The resolution of coronary collaterals after successful percutaneous transluminal coronary angioplasty.
L. Klein (1988)
10.1056/NEJM198708133170706
Statistical problems in the reporting of clinical trials. A survey of three medical journals.
S. Pocock (1987)
10.1002/AJH.2830170310
Effect of heparin on platelet aggregation
H. Saba (1984)
10.1002/CCD.1810140304
Unusually long inflation times during percutaneous transluminal coronary angioplasty.
A. Palazzo (1988)
10.1161/01.CIR.63.4.793
Clinical and Angiographic Predictors of Operative Mortality from the Collaborative Study in Coronary Artery Surgery (CASS)
J. W. Kennedy (1981)
10.1182/BLOOD.V68.3.783.BLOODJOURNAL683783
Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model.
Barry S. Coller (1986)
10.1016/0002-9149(88)90960-5
Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial.
E. Topol (1988)
10.1016/0002-9149(85)90874-4
Percutaneous transluminal coronary angioplasty after previous coronary artery bypass surgery.
J. Corbelli (1985)
10.1016/0002-9149(84)90533-2
Distal embolization of a coronary artery bypass graft atheroma during percutaneous transluminal coronary angioplasty.
F. Aueron (1984)
10.1016/0735-1097(88)90401-9
Coronary angioplasty for unstable angina: immediate and late results in 200 consecutive patients with identification of risk factors for unfavorable early and late outcome.
P. D. de Feyter (1988)
10.1016/0735-1097(88)91532-X
Echocardiographic visualization of coronary artery anatomy in the adult.
P. Douglas (1988)
10.1136/hrt.61.5.417
Percutaneous transluminal angioplasty of left internal mammary artery grafts: two years' experience with a femoral approach.
M. Bell (1989)
10.1016/0002-8703(88)90326-2
Acute coronary occlusion occurring after successful percutaneous transluminal coronary angioplasty: temporal relationship to discontinuation of anticoagulation.
G. Gabliani (1988)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar